Epothilone-B 0.0015μM R05 exp231 [The Human Chemical-Genetic Interaction Map Project]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.
====== Epothilone-B 0.0015μM R05 exp231 ======
==== Mechanism of Action ====
Inhibits microtubule depolymerization, parent compound of ixabepilone
  * **<color #00a2e8>Class / Subclass 1:</color>** Cell Cycle / Microtubule Poison
  * **<color #00a2e8>Class / Subclass 2:</color>** Organelle Function / Cytoskeletal Inhibitor



==== Technical Notes ====
<accordion collapsed='true'>
<panel title='Compound References' collapsed='true'>
    * **<color #00a2e8>PubChem Name:</color>** %%Epothilone B%%
    * **<color #00a2e8>Synonyms:</color>** EPO 906; Patupilone
    * **<color #00a2e8>CAS #:</color>** 152044-54-7
    * **<color #00a2e8>PubChem CID:</color>** [[https://pubchem.ncbi.nlm.nih.gov/compound/448013|448013]]
    * **<color #00a2e8>IUPAC:</color>** %%(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione%%
    * **<color #00a2e8>INCHI Name:</color>** InChI=1S/C27H41NO6S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)33-23(30)13-21(29)26(5,6)25(32)17(3)24(15)31/h11,14-15,17,20-22,24,29,31H,8-10,12-13H2,1-7H3/b16-11+/t15-,17+,20-,21-,22-,24-,27+/m0/s1
    * **<color #00a2e8>INCHI Key:</color>** QXRSDHAAWVKZLJ-PVYNADRNSA-N
    * **<color #00a2e8>Molecular Weight:</color>** 507.7
    * **<color #00a2e8>Canonical SMILES:</color>** CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C
    * **<color #00a2e8>Isomeric SMILES:</color>** C[C@H]1CCC[C@@]2([C@@H](O2)C[C@H](OC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C)C
    * **<color #00a2e8>Molecular Formula:</color>** C27H41NO6S
{{:chemogenomics:structures:chem-0136.svg?nolink}}
</panel>


<panel title='Compound Supplier' collapsed='true'>
    * **<color #00a2e8>Supplier Name:</color>** Sigma-Aldrich
    * **<color #00a2e8>Catalog #:</color>** E2656
    * **<color #00a2e8>Lot #:</color>** N/A
</panel>


<panel title='Compound Characterization' collapsed='true'>
    * **<color #00a2e8>HRMS (ESI-TOF) m/z:</color>** (M+H)+ Calcd for C27H41NO6S 508.27274; found 508.27356
</panel>


<panel title='Dose Response Curve' collapsed='true'>
    * **<color #00a2e8>Platform ID:</color>** Epithilone-B
    * **<color #00a2e8>Min:</color>** -7.4834; **<color #00a2e8>Max:</color>** 85.8439
{{:chemogenomics:dose_response:dr_213.png?nolink&500 |}}
\\ 
\\ 
\\ 
\\ 
|< 300px 100px 200px >|
^ IC   ^ Concentration (µM) ^
| IC10  |N/A    |
| IC20  |0.0010    |
| IC30  |0.0014    |
| IC40  |0.0019    |
| IC50  |0.0025    |
| IC60  |N/A    |
| IC70  |N/A    |
| IC80  |N/A    |
| IC90  |N/A    |
\\ 
</panel>
</accordion>
==== Screen Summary ====
    * **<color #00a2e8>Round</color>**: 05
    * **<color #00a2e8>Dose</color>**: 1.5nM
    * **<color #00a2e8>Days of incubation</color>**: 8
    * **<color #00a2e8>Doublings</color>**: 4.8
    * **<color #00a2e8>Numbers of reads</color>**: 20868466


==== Screen Results ====


^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^
|14/10|<color #e85500>[[https://files.tyerslab.com/files/public/chemogenomics/cranks/Epothilone_B_0.0015uM_Round-5_exp231.txt|Scores]]</color>|<button type="primary" size="sm" modal="ScorePlot">View</button>|<button type="primary" size="sm" modal="modal_hits">View</button>|<button type="primary" size="sm" modal="modal_screen_similarity">View</button>|<button type="primary" size="sm" modal="modal_go_sensitive">View</button>|<button type="primary" size="sm" modal="modal_go_resistant">View</button>|
<modal id='ScorePlot' size='lg' title='Epothilone-B 0.0015μM R05 exp231'>
{{:chemogenomics:cranks_plots:exp231.png?nolink}}
</modal>


<modal id="modal_hits" size="sm" title="Top 30 S/R Genes">
^Gene^CRANKS Score^FDR^
|[[:human_genes:K:KIF18B|KIF18B]]|-4.26|<0.01|
|[[:human_genes:Q:QRICH1|QRICH1]]|-3.73|<0.01|
|[[:human_genes:W:WDR62|WDR62]]|-3.66|<0.01|
|[[:human_genes:K:KATNA1|KATNA1]]|-3.57|<0.01|
|[[:human_genes:C:CEP170|CEP170]]|-3.36|<0.01|
|[[:human_genes:K:KIF2A|KIF2A]]|-3.24|<0.01|
|[[:human_genes:R:RHOA|RHOA]]|-3.18|<0.01|
|[[:human_genes:G:GNA13|GNA13]]|-3.04|<0.01|
|[[:human_genes:T:TCF4|TCF4]]|-2.81|<0.01|
|[[:human_genes:S:SEPHS2|SEPHS2]]|-2.79|<0.01|
|[[:human_genes:D:DYNLT1|DYNLT1]]|-2.71|0.01|
|[[:human_genes:E:ESCO2|ESCO2]]|-2.63|0.01|
|[[:human_genes:S:SGOL2|SGOL2]]|-2.53|0.02|
|[[:human_genes:H:HMMR|HMMR]]|-2.49|0.06|
|[[:human_genes:G:GTSE1|GTSE1]]|-2.47|0.06|
|[[:human_genes:P:PRKAA1|PRKAA1]]|-2.42|0.04|
|[[:human_genes:S:SEPSECS|SEPSECS]]|-2.42|0.07|
|[[:human_genes:N:NPRL3|NPRL3]]|-2.40|0.14|
|[[:human_genes:M:MSI2|MSI2]]|-2.37|0.06|
|[[:human_genes:B:BUB1B|BUB1B]]|-2.33|0.10|
|[[:human_genes:T:TACC3|TACC3]]|-2.32|0.06|
|[[:human_genes:U:UBE2QL1|UBE2QL1]]|-2.30|0.15|
|[[:human_genes:S:SOD1|SOD1]]|-2.28|0.15|
|[[:human_genes:C:CANX|CANX]]|-2.27|0.15|
|[[:human_genes:P:PHACTR4|PHACTR4]]|-2.26|0.08|
|[[:human_genes:R:RIC8A|RIC8A]]|-2.23|0.09|
|[[:human_genes:S:SIN3A|SIN3A]]|-2.23|0.15|
|[[:human_genes:C:CDC37|CDC37]]|-2.21|0.19|
|[[:human_genes:G:GSG2|GSG2]]|-2.19|0.15|
|[[:human_genes:A:ARFRP1|ARFRP1]]|-2.18|0.11|
|[[:human_genes:H:H2AFB3|H2AFB3]]|2.13|0.16|
|[[:human_genes:H:H2AFB2|H2AFB2]]|2.15|0.16|
|[[:human_genes:U:UNK|UNK]]|2.21|0.17|
|[[:human_genes:E:EIF3E|EIF3E]]|2.24|0.23|
|[[:human_genes:S:SSSCA1|SSSCA1]]|2.24|0.23|
|[[:human_genes:T:TTC19|TTC19]]|2.25|0.10|
|[[:human_genes:A:ATP1A1|ATP1A1]]|2.25|0.16|
|[[:human_genes:S:SAMHD1|SAMHD1]]|2.26|0.16|
|[[:human_genes:O:OR4M2|OR4M2]]|2.26|0.37|
|[[:human_genes:S:SLC25A51|SLC25A51]]|2.29|0.09|
|[[:human_genes:A:ARID4B|ARID4B]]|2.31|0.15|
|[[:human_genes:C:C1orf21|C1orf21]]|2.31|0.09|
|[[:human_genes:P:PKMYT1|PKMYT1]]|2.32|0.17|
|[[:human_genes:C:CSNK2A1|CSNK2A1]]|2.35|0.08|
|[[:human_genes:K:KPNB1|KPNB1]]|2.45|0.38|
|[[:human_genes:P:PSMA8|PSMA8]]|2.45|0.09|
|[[:human_genes:U:USP22|USP22]]|2.50|0.04|
|[[:human_genes:D:DDX46|DDX46]]|2.52|0.45|
|[[:human_genes:M:MDM2|MDM2]]|2.54|0.17|
|[[:human_genes:P:PFDN4|PFDN4]]|2.55|0.03|
|[[:human_genes:M:MAPKAPK5|MAPKAPK5]]|2.56|0.06|
|[[:human_genes:H:HK2|HK2]]|2.75|0.10|
|[[:human_genes:N:NUP188|NUP188]]|2.84|0.02|
|[[:human_genes:C:CMIP|CMIP]]|3.01|<0.01|
|[[:human_genes:T:TUBA1B|TUBA1B]]|3.64|<0.01|
|[[:human_genes:P:PFDN5|PFDN5]]|3.67|<0.01|
|[[:human_genes:A:AHCYL1|AHCYL1]]|5.01|<0.01|
|[[:human_genes:T:TUBB4B|TUBB4B]]|5.57|<0.01|
|[[:human_genes:V:VBP1|VBP1]]|5.64|<0.01|
|[[:human_genes:C:CLASP1|CLASP1]]|5.94|<0.01|
</modal>


<modal id="modal_screen_similarity" size="lg" title="Correlated Screens">
^Screen^Correlation^Plot^
|[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|0.16|<button type="primary" size="small" modal="1">View</button>|
|[[:results:exp103|Taxol 0.004μM R03 exp103]]|0.155|<button type="primary" size="small" modal="2">View</button>|
|[[:results:exp232|Epothilone-D 0.004 to 0.006μM on day4 R05 exp232]]|0.085|<button type="primary" size="small" modal="3">View</button>|
|[[:results:exp217|Mdivi-1 15μM R05 exp217]]|0.065|<button type="primary" size="small" modal="4">View</button>|
|[[:results:exp517|Quercetin 20μM R08 exp517]]|0.062|<button type="primary" size="small" modal="5">View</button>|
|[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|0.06|<button type="primary" size="small" modal="6">View</button>|
|[[:results:exp107|UMK57 0.6μM R03 exp107]]|0.058|<button type="primary" size="small" modal="7">View</button>|
|[[:results:exp243|S-trityl-L-cysteine 0.5μM R05 exp243]]|0.057|<button type="primary" size="small" modal="8">View</button>|
|[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|0.056|<button type="primary" size="small" modal="9">View</button>|
|[[:results:exp59|UMK57 1μM R01 exp59]]|0.053|<button type="primary" size="small" modal="10">View</button>|
|[[:results:exp360|Genistein 15μM R07 exp360]]|0.051|<button type="primary" size="small" modal="11">View</button>|
|[[:results:exp223|Cabazitaxel 0.001μM R05 exp223]]|0.152|<button type="primary" size="small" modal="12">View</button>|
|[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|0.083|<button type="primary" size="small" modal="13">View</button>|
|[[:results:exp159|Docetaxel 0.001 to 0.002μM on day4 R04 exp159]]|0.083|<button type="primary" size="small" modal="14">View</button>|
|[[:results:exp460|BML-284 0.09μM R08 exp460]]|0.076|<button type="primary" size="small" modal="15">View</button>|
|[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|0.061|<button type="primary" size="small" modal="16">View</button>|
|[[:results:exp215|Colchicine 0.009μM R05 exp215]]|0.056|<button type="primary" size="small" modal="17">View</button>|
|[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|0.052|<button type="primary" size="small" modal="18">View</button>|
</modal>


<modal id="1" size="lg" title="Epothilone-B 0.0015μM R05 exp231  vs  Ixabepilone 0.004 to 0.005μM on day4 R04 exp184">
{{:chemogenomics:comparison_plots:exp184_vs_exp231.png?nolink |}}
</modal>

<modal id="2" size="lg" title="Epothilone-B 0.0015μM R05 exp231  vs  Taxol 0.004μM R03 exp103">
{{:chemogenomics:comparison_plots:exp103_vs_exp231.png?nolink |}}
</modal>

<modal id="3" size="lg" title="Epothilone-B 0.0015μM R05 exp231  vs  Epothilone-D 0.004 to 0.006μM on day4 R05 exp232">
{{:chemogenomics:comparison_plots:exp231_vs_exp232.png?nolink |}}
</modal>

<modal id="4" size="lg" title="Epothilone-B 0.0015μM R05 exp231  vs  Mdivi-1 15μM R05 exp217">
{{:chemogenomics:comparison_plots:exp217_vs_exp231.png?nolink |}}
</modal>

<modal id="5" size="lg" title="Epothilone-B 0.0015μM R05 exp231  vs  Quercetin 20μM R08 exp517">
{{:chemogenomics:comparison_plots:exp231_vs_exp517.png?nolink |}}
</modal>

<modal id="6" size="lg" title="Epothilone-B 0.0015μM R05 exp231  vs  Vincristine 0.0005μM R04 exp190">
{{:chemogenomics:comparison_plots:exp190_vs_exp231.png?nolink |}}
</modal>

<modal id="7" size="lg" title="Epothilone-B 0.0015μM R05 exp231  vs  UMK57 0.6μM R03 exp107">
{{:chemogenomics:comparison_plots:exp107_vs_exp231.png?nolink |}}
</modal>

<modal id="8" size="lg" title="Epothilone-B 0.0015μM R05 exp231  vs  S-trityl-L-cysteine 0.5μM R05 exp243">
{{:chemogenomics:comparison_plots:exp231_vs_exp243.png?nolink |}}
</modal>

<modal id="9" size="lg" title="Epothilone-B 0.0015μM R05 exp231  vs  LY2090314 0.003μM R08 exp500 no dilution day6">
{{:chemogenomics:comparison_plots:exp231_vs_exp500.png?nolink |}}
</modal>

<modal id="10" size="lg" title="Epothilone-B 0.0015μM R05 exp231  vs  UMK57 1μM R01 exp59">
{{:chemogenomics:comparison_plots:exp231_vs_exp59.png?nolink |}}
</modal>

<modal id="11" size="lg" title="Epothilone-B 0.0015μM R05 exp231  vs  Genistein 15μM R07 exp360">
{{:chemogenomics:comparison_plots:exp231_vs_exp360.png?nolink |}}
</modal>

<modal id="12" size="lg" title="Cabazitaxel 0.001μM R05 exp223  vs  Epothilone-B 0.0015μM R05 exp231">
{{:chemogenomics:comparison_plots:exp223_vs_exp231.png?nolink |}}
</modal>

<modal id="13" size="lg" title="Docetaxel 0.002μM R01 exp45  vs  Epothilone-B 0.0015μM R05 exp231">
{{:chemogenomics:comparison_plots:exp231_vs_exp45.png?nolink |}}
</modal>

<modal id="14" size="lg" title="Docetaxel 0.001 to 0.002μM on day4 R04 exp159  vs  Epothilone-B 0.0015μM R05 exp231">
{{:chemogenomics:comparison_plots:exp159_vs_exp231.png?nolink |}}
</modal>

<modal id="15" size="lg" title="BML-284 0.09μM R08 exp460  vs  Epothilone-B 0.0015μM R05 exp231">
{{:chemogenomics:comparison_plots:exp231_vs_exp460.png?nolink |}}
</modal>

<modal id="16" size="lg" title="Combretastatin A4 0.002 to 0.003μM day4 R04 exp179  vs  Epothilone-B 0.0015μM R05 exp231">
{{:chemogenomics:comparison_plots:exp179_vs_exp231.png?nolink |}}
</modal>

<modal id="17" size="lg" title="Colchicine 0.009μM R05 exp215  vs  Epothilone-B 0.0015μM R05 exp231">
{{:chemogenomics:comparison_plots:exp215_vs_exp231.png?nolink |}}
</modal>

<modal id="18" size="lg" title="Demecolcine 0.03μM R05 exp228  vs  Epothilone-B 0.0015μM R05 exp231">
{{:chemogenomics:comparison_plots:exp228_vs_exp231.png?nolink |}}
</modal>



<modal id="modal_go_sensitive" size="lg" title="Top 30 sensitive GO terms">
^GO Term^Fold Change^Genes^
|mitotic spindle organization|24.06|WDR62,KIF2A,RHOA,TACC3|
|microtubule cytoskeleton organization involved in mitosis|22.15|WDR62,KIF2A,RHOA,DYNLT1,TACC3|
|spindle|13.80|KIF18B,WDR62,KATNA1,CEP170,KIF2A,DYNLT1,HMMR,BUB1B,TACC3,HASPIN|
|mitotic cell cycle process|9.93|KIF18B,WDR62,KIF2A,RHOA,DYNLT1,GTSE1,BUB1B,TACC3,HASPIN|
|chromosome organization|9.07|KIF18B,KIF2A,RHOA,ESCO2,SGO2,BUB1B,HASPIN|
|cell division|9.03|KIF18B,KATNA1,KIF2A,RHOA,DYNLT1,SGO2,BUB1B,TACC3|
|mitotic cell cycle|8.54|KIF18B,WDR62,KIF2A,RHOA,DYNLT1,GTSE1,BUB1B,TACC3,HASPIN|
|cell cycle process|7.19|KIF18B,WDR62,KIF2A,RHOA,DYNLT1,ESCO2,SGO2,GTSE1,BUB1B,TACC3,HASPIN|
|microtubule-based process|6.59|KIF18B,WDR62,KATNA1,KIF2A,RHOA,DYNLT1,GTSE1,TACC3,SOD1|
</modal>
<modal id="modal_go_resistant" size="lg" title="Top 30 resistant GO terms">
^GO Term^Fold Change^Genes^
|regulation of amyloid fibril formation|110.47|VBP1,PFDN5,PFDN4|
|chaperone-mediated protein folding|39.45|VBP1,PFDN5,PFDN4,CSNK2A1,TCP1|
|unfolded protein binding|25.34|VBP1,TUBB4B,PFDN5,PFDN4,TCP1|
|mitotic cell cycle|7.34|CLASP1,TUBB4B,TUBA1B,MDM2,KPNB1,PKMYT1,TTC19,ZNRD2|
</modal>